After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

104 trades

Disclosure transactions for Regeneron Pharmaceuticals Inc
Reporting person Filed Transaction Transaction value Source Actions
Guarini Kathryn Director Sep 3, 2026 1-day lag Exercise Sep 2, 2026 $287.75K Filed shares x price SEC Form 4 View filing
Larosa Joseph J EVP General Counsel And Secret Aug 21, 2026 2-day lag Exercise Aug 19, 2026 $0 Filed shares x price SEC Form 4 View filing
Larosa Joseph J EVP General Counsel And Secret Aug 21, 2026 2-day lag Exercise Aug 19, 2026 $4.69M Filed shares x price SEC Form 4 View filing
Larosa Joseph J EVP General Counsel And Secret Aug 21, 2026 2-day lag Disposition Aug 19, 2026 $7.49M Filed shares x price SEC Form 4 View filing
Fenimore Christopher R. EVP Finance CFO Aug 20, 2026 2-day lag Exercise Aug 18, 2026 $2.4M Filed shares x price SEC Form 4 View filing
Fenimore Christopher R. EVP Finance CFO Aug 20, 2026 2-day lag Exercise Aug 18, 2026 $0 Filed shares x price SEC Form 4 View filing
Fenimore Christopher R. EVP Finance CFO Aug 20, 2026 2-day lag Disposition Aug 18, 2026 $3.74M Filed shares x price SEC Form 4 View filing
Guarini Kathryn Director Aug 12, 2026 2-day lag Exercise Aug 10, 2026 $0 Filed shares x price SEC Form 4 View filing
Guarini Kathryn Director Aug 12, 2026 2-day lag Exercise Aug 10, 2026 $287.75K Filed shares x price SEC Form 4 View filing
Guarini Kathryn Director Aug 12, 2026 2-day lag Sale Aug 10, 2026 $320K Filed shares x price SEC Form 4 View filing
Zoghbi Huda Y Director Aug 12, 2026 2-day lag Exercise Aug 10, 2026 $0 Filed shares x price SEC Form 4 View filing
Zoghbi Huda Y Director Aug 12, 2026 2-day lag Exercise Aug 10, 2026 $301.35K Filed shares x price SEC Form 4 View filing
Zoghbi Huda Y Director Aug 12, 2026 2-day lag Sale Aug 10, 2026 $640K Filed shares x price SEC Form 4 View filing
Ryan Arthur F Director Jul 7, 2026 5-day lag Sale Jul 2, 2026 $130.03K Filed shares x price SEC Form 4 View filing
Guarini Kathryn Director
Exercise
Calculated transaction value
$287.75K 400 shares @ $719.37
Traded
Sep 2, 2026
Filed
Sep 3, 2026
Larosa Joseph J EVP General Counsel And Secret
Exercise
Calculated transaction value
$0 12,282 shares @ $0
Traded
Aug 19, 2026
Filed
Aug 21, 2026
Larosa Joseph J EVP General Counsel And Secret
Exercise
Calculated transaction value
$4.69M 12,282 shares @ $381.92
Traded
Aug 19, 2026
Filed
Aug 21, 2026
Larosa Joseph J EVP General Counsel And Secret
Disposition
Calculated transaction value
$7.49M 9,019 shares @ $830.15
Traded
Aug 19, 2026
Filed
Aug 21, 2026
Fenimore Christopher R. EVP Finance CFO
Exercise
Calculated transaction value
$2.4M 6,283 shares @ $381.92
Traded
Aug 18, 2026
Filed
Aug 20, 2026
Fenimore Christopher R. EVP Finance CFO
Exercise
Calculated transaction value
$0 6,283 shares @ $0
Traded
Aug 18, 2026
Filed
Aug 20, 2026
Fenimore Christopher R. EVP Finance CFO
Disposition
Calculated transaction value
$3.74M 4,599 shares @ $813.47
Traded
Aug 18, 2026
Filed
Aug 20, 2026
Guarini Kathryn Director
Exercise
Calculated transaction value
$0 400 shares @ $0
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Guarini Kathryn Director
Exercise
Calculated transaction value
$287.75K 400 shares @ $719.37
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Guarini Kathryn Director
Sale
Calculated transaction value
$320K 400 shares @ $800
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Zoghbi Huda Y Director
Exercise
Calculated transaction value
$0 800 shares @ $0
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Zoghbi Huda Y Director
Exercise
Calculated transaction value
$301.35K 800 shares @ $376.69
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Zoghbi Huda Y Director
Sale
Calculated transaction value
$640K 800 shares @ $800
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Ryan Arthur F Director
Sale
Calculated transaction value
$130.03K 200 shares @ $650.15
Traded
Jul 2, 2026
Filed
Jul 7, 2026